{"name": "Quark Pharmaceuticals",
 "permalink": "quark-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/quark-pharmaceuticals",
 "homepage_url": "http://www.quarkpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1994,
 "founded_month": 12,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "genes, sirna, diseases, bifar",
 "alias_list": "",
 "email_address": "qbi@quarkpharma.com",
 "phone_number": "510-402-4020",
 "description": "",
 "created_at": "Thu Jun 04 00:59:23 UTC 2009",
 "updated_at": "Thu Oct 07 05:28:26 UTC 2010",
 "overview": "\u003Cp\u003E\u0026#8220;Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the \u00e2\u20ac\u0153BiFAR\u00e2\u20ac\u009d technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark\u00e2\u20ac\u2122s approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.\u0026#8221;\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0004/6573/46573v1-max-150x150.png"],
     [[168,
       51],
      "assets/images/resized/0004/6573/46573v1-max-250x250.png"],
     [[168,
       51],
      "assets/images/resized/0004/6573/46573v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Daniel",
      "last_name": "Zurr",
      "permalink": "daniel-zurr",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Rami",
      "last_name": "Skaliter",
      "permalink": "rami-skaliter",
      "image": null}},
   {"is_past": false,
    "title": "Chief Development Officer",
    "person":
     {"first_name": "Shai",
      "last_name": "Erlich",
      "permalink": "shai-erlich",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$27M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 27000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 7,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SBI Asset Management",
         "permalink": "sbi-asset-management",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0007/5626/75626v1-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0007/5626/75626v1-max-250x250.png"],
             [[345,
               71],
              "assets/images/resized/0007/5626/75626v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SBI Investment",
         "permalink": "sbi-investment",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0007/5630/75630v1-max-150x150.png"],
             [[193,
               57],
              "assets/images/resized/0007/5630/75630v1-max-250x250.png"],
             [[193,
               57],
              "assets/images/resized/0007/5630/75630v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "6501 Dumbarton Circle. ",
    "address2": "",
    "zip_code": "94555",
    "city": "Fremont",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.5511524,
    "longitude": -122.060501}],
 "milestones":
  [{"description": "Quark Pharmaceuticals Files For IPO On Tel Aviv Stock Exchange",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 27,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100925e69r00003\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "Quark Pharmaceuticals Files For IPO On Tel Aviv Stock Exchange",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Quark Pharmaceuticals",
      "permalink": "quark-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0004/6572/46572v1-max-150x150.jpg"],
      [[250,
        133],
       "assets/images/resized/0004/6572/46572v1-max-250x250.jpg"],
      [[450,
        239],
       "assets/images/resized/0004/6572/46572v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}